Management of hyponatremia

CMAJ. 2014 May 13;186(8):E281-6. doi: 10.1503/cmaj.120887. Epub 2013 Dec 16.
No abstract available

Publication types

  • Review

MeSH terms

  • Antidiuretic Hormone Receptor Antagonists*
  • Benzamides / therapeutic use
  • Benzazepines / therapeutic use
  • Disease Management
  • Female
  • Humans
  • Hyponatremia / diagnosis*
  • Hyponatremia / drug therapy*
  • Hypovolemia / diagnosis
  • Hypovolemia / therapy
  • Inappropriate ADH Syndrome / diagnosis*
  • Inappropriate ADH Syndrome / therapy
  • Male
  • Morpholines / therapeutic use
  • Prognosis
  • Pyrroles / therapeutic use
  • Receptors, Vasopressin / therapeutic use
  • Risk Assessment
  • Severity of Illness Index
  • Spiro Compounds / therapeutic use
  • Tolvaptan
  • Treatment Outcome

Substances

  • Antidiuretic Hormone Receptor Antagonists
  • Benzamides
  • Benzazepines
  • Morpholines
  • Pyrroles
  • Receptors, Vasopressin
  • Spiro Compounds
  • conivaptan
  • Tolvaptan
  • lixivaptan
  • satavaptan